Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke (Q24201855)

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Recombinant human erythropoietin in the treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte-colony-stimulating Factor for Acute Ischemic Stroke: A Randomized Controlled Trial (STEMTHER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease--a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Stem cell factor stimulates neurogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

G-CSF protects human cerebral hybrid neurons against in vitro ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Intracarotid injection of granulocyte-macrophage colony-stimulating factor induces neuroprotection in a rat transient middle cerebral artery occlusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Role of endogenous granulocyte-macrophage colony stimulating factor following stroke and relationship to neurological outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Effects of granulocyte-colony stimulating factor after stroke in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Brain repair by hematopoietic growth factors in a rat model of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

Serum macrophage colony-stimulating factor (M-CSF) level is elevated in patients with old cerebral infarction related to vascular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

7 January 2021

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

7 January 2021

Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

7 January 2021

Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005207.PUB4

7 January 2021

10.1002/14651858.CD005207.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23797623

1 reference

Consolidated OpenCitations Corpus – April 2017